(Q53967094)

23 May 2018

title

Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines. (English)

1 reference

23 May 2018

1 reference

Hong JH

1

1 reference

23 May 2018

Lee E

2

1 reference

23 May 2018

Hong J

3

1 reference

23 May 2018

Shin YJ

4

1 reference

23 May 2018

Ahn H

5

1 reference

23 May 2018

publication date

1 July 2002

1 reference

23 May 2018

published in

BJU International

1 reference

23 May 2018

volume

90

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

113-117

1 reference

23 May 2018

Overexpression of metallothionein confers resistance to anticancer drugs.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Programmed cell death and radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Methods of gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02799.X

10.1046/J.1464-410X.2002.02799.X

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

12081782

1 reference

23 May 2018